![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tetzlaff Eric D Cen Putao Ajani Jaffer A
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.13, Iss.1, 2008-03, pp. : 135-144
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for colorectal cancer
By Fogelman David R Kopetz Scott Eng Cathy
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. :